F. S. Nielsen
Novo Nordisk (Denmark)(DK)
Publications by Year
Research Areas
Blood Pressure and Hypertension Studies, Chronic Kidney Disease and Diabetes, Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Cardiovascular Health and Disease Prevention
Most-Cited Works
- → Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide(2015)989 cited
- → Albuminuria and poor glycemic control predict mortality in NIDDM(1995)313 cited
- → Lack of Relationship Between an Insertion/Deletion Polymorphism in the Angiotensin I–Converting Enzyme Gene and Diabetic Nephropathy and Proliferative Retinopathy in IDDM Patients(1995)190 cited
- → Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V(1994)184 cited
- → Long-Term Effect of Lisinopril and Atenolol on Kidney Function in Hypertensive NIDDM Subjects With Diabetic Nephropathy(1997)177 cited
- → Glomerular structure and function in proteinuric Type 2 (non-insulin-dependent) diabetic patients(1993)172 cited
- → The course of kidney function in Type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy(1993)157 cited
- → Bioavailability of probucol from lipid and surfactant based formulations in minipigs: Influence of droplet size and dietary state(2008)153 cited
- → Structural Development of Self Nano Emulsifying Drug Delivery Systems (SNEDDS) During In Vitro Lipid Digestion Monitored by Small-angle X-ray Scattering(2007)129 cited